Cargando…
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
BACKGROUND: It is known that suboptimal adherence rates may affect endocrine treatments for breast cancer, but little information has been reported whether any efforts to improve treatment adherence have been successful. We designed a randomized, controlled study to investigate the effect of oral or...
Autores principales: | Ziller, Volker, Kyvernitakis, Ioannis, Knöll, Dana, Storch, Astrid, Hars, Olaf, Hadji, Peyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844591/ https://www.ncbi.nlm.nih.gov/pubmed/24006873 http://dx.doi.org/10.1186/1471-2407-13-407 |
Ejemplares similares
-
Compás
por: Bonifaz, Marirrós, 1957-
Publicado: (2002) -
Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral Fractures
por: Hadji, Peyman, et al.
Publicado: (2022) -
Cógele bien el compás /
por: Rodríguez Solís, Eduardo
Publicado: (1991) -
El compás de madera
por: Fonseca Leyva, Francisco
Publicado: (1982) -
Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study
por: Bryce, Jane, et al.
Publicado: (2012)